FDA approves first therapy to treat patients with rare blood disorder
The U.S. Food and Drug Administration has granted approval to Reblozyl (luspatercept–aamt) for the treatment of anemia (lack of red blood cells) in adult patients with beta thalassemia who require regular red blood cell (RBC) transfusions... read more
Pakistan accused of cover-up over fresh polio outbreak
Officials in Pakistan have been accused of covering up an outbreak of the most dangerous strain of polio and planning a covert vaccination programme to contain the disease.
According to a source in Pakistan’s polio eradication programme and documentation seen by the Guardian,... read more
IITs told to bring projects on curbing pollution to Delhi
NEW DELHI: The Union HRD ministry has asked all the IITs to bring to Delhi their innovations on curbing air pollution, reflecting the urgency showed by the Supreme Court and the Prime Minister's Office.
The SC had specifically asked the Centre to seek the help of IITs to find a solution to the crisis... read more
First native Zika cases in Europe confirmed as experts warn climate change could bring more
The first native cases of Zika in Europe have been confirmed after three people became infected with the virus in France. Experts warn that climate change could lead to more cases emerging across the continent.
Three people caught Zika in Hyères, southern France, in August this year,... read more
Copper ICU Beds Mostly Untarnished by Bacteria
Hospital beds with copper surfaces in an intensive care unit had significantly fewer bacteria than hospital beds with plastic surfaces, even after daily cleaning and disinfection, researchers found.
Active colony forming units per 100 cm2 on beds with copper rails,... read more
Investigational Drug Reduces Body Fat in Obese Patients With Diabetes
An investigational agent, bimagrumab — which was originally being tested to see if it would increase lean muscle mass in people with sarcopenia — is effective and safe for weight loss, according to preliminary results from a study in patients with obesity and type 2 diabetes... read more
Acute Kidney Injury Common With Immune Checkpoint Inhibitors
About one in six cancer patients treated with immune-checkpoint inhibitors develops at least transient acute kidney injury (AKI), a retrospective study found.
In a review of data on more than 1,000 cancer patients who received checkpoint inhibitors between 2011... read more